David Moatazedi

David Moatazedi joined the organization as President and Chief Executive Officer in May 2018. Mr. Moatazedi formerly served as Senior Vice President of U.S. Medical Aesthetics at Allergan™, leading the entire aesthetic portfolio of brands including Botox® Cosmetic, JUVEDERM® Collection, CoolSculpting®, KYBELLA®, SkinMedica®, Latisse®, Natrelle® and Alloderm®.
Mr. Moatazedi has nearly twenty years of commercial and executive experience building multiple market-leading brands. David also led several acquisitions for Allergan, including LifeCell™ for $2.9B and ZELTIQ® Aesthetics for $2.5B.

Prior to Mr. Moatazedi’s thirteen years at Allergan, he spent six years at Novartis Pharmaceuticals. He holds an MBA in Marketing from Pepperdine University and a B.A. in Chemistry from California State University, Long Beach.